Albireo Pharma Inc
Biotechnology
Healthcare
ALBO
19.66 M shares
NASDAQ US
traded
02 Mar 2023
listed
yes
open
44.90
52 week high
44.95
high
44.90
52 week low
16.32
low
44.00
growth
37.33 %
previous Close
44.25
P/E ratio
-23
market cap
916 M
div yield
0
usd
Sep 2022
qoq
revenue
9.83 M
19.81 %
net incoming
-37.80 M
5.38 %
eps
-1.92 %
5.88 %
eps surprise
-81.13 %
net profit margin
-384.46 %
102.00 %
operating incoming
-34.66 M
6.85 %
net change in cash
91.51 M
359.40 %
cash on hand
222 M
22.93 %
cost of revenue
612 K
-98.65 %
top top